Home › Esophageal Adenocarcinoma › New Jersey › Edison
Esophageal Adenocarcinoma clinical trials in Edison, NJ
4 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- START Astera, LLC, East Brunswick · 6 mi away
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
RecruitingPhase 1/2
- Memorial Sloan Kettering at Basking Ridge (Limited protocol activities), Basking Ridge · 15 mi away
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, New Brunswick · 3 mi away
- Research Site, East Brunswick · 6 mi away
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- St. Louis, MO9 studies
- Jacksonville, FL9 studies
- Rochester, MN9 studies
- Baldwin Park, CA9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Edison
- Breast Cancer68 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer20 studies
- Metastatic Cancer20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.